期刊文献+

稀化黏素胶囊和布地奈德鼻喷雾剂治疗分泌性中耳炎临床疗效分析

Observation on therapeutic effect of standardized myrtol and budesonide on secretary otitis media
下载PDF
导出
摘要 目的观察稀化黏素和布地奈德治疗分泌性中耳炎(SOM)的疗效。方法232例(280耳)分泌性中耳炎病人中治疗组124例(150耳),在常规用药的基础上加服稀化黏素,并使用布地奈德喷鼻;对照组108例(130耳),予常规用药治疗。2、3周后随访,观察两组治疗前后症状、体征、纯音测听和鼓室压图的变化。结果治疗组主观症状、耳部检查、纯音测听、声阻抗检查等各项观察指标总有效率分别为94.0%、94.7%、93.3%和94.0%,与对照组各项观察指标总有效率64.6%、73.9%、63.8%和64.6%比较,治疗组均优于对照组,差异均有显著性(P<0.05)。结论口服稀化黏素并鼻腔喷用布地奈德能有效提高分泌性中耳炎的临床疗效。 Objective To observe the therapeutic effect of standardized myrtol and budesonide on secretary otitis media(SOM).Methods Two hundred and thirty two patients(280 ears)with SOM were randomly divided into two groups,124 cases(150 ears)in treatment group were treated with routine medication combined with oral administration of standardized myrtol and nasally spraying budesonide,and 108 cases(130 ears)in control group were only treated with routine medication.Changes in symptoms,signs,graphes of tympanil pressure and pure-tone audiometry were observed among patients of these two groups in 2~3 weeks after treatment.Results Subjective symptoms,ear examination,pure tone audiometry,acoustic impedance etc were observed as indicators for check,and their total effective rates in patients of treatment group were 94.0%,94.7%,93.3% and 94.0% respectively,and they were better than those of 64.6%,73.9%,63.8% and 64.6% respectively in patients of control group.Their differences were statistically significant(P0.05).Conclusion Oral administration of standardized myrtol combined with nasally spraying budesonide can improve the therapeutic effect of patients with SOM.
作者 陈锡佐
机构地区 乐至县中医院
出处 《临床和实验医学杂志》 2009年第11期44-45,共2页 Journal of Clinical and Experimental Medicine
关键词 分泌性中耳炎 稀化黏素 布地奈德 Secretory otitis media Myrtol standardized Budesonide
  • 相关文献

参考文献5

二级参考文献16

  • 1沈宝茗,江青山,廖剑绚,谭凤君,唐洪波.沙眼衣原体感染与分泌性中耳炎的关系[J].临床耳鼻咽喉头颈外科杂志,2007,21(13):590-592. 被引量:2
  • 2Johnson MD,Fitzgerald JE,Leonard G,et al.Cytokines in experimental otitis media with effusion. Laryngoscope,1994,104:191-196.
  • 3Maxwell K,Leonard G,Kreutzer DL.Cytokine expression in otitis media with effusion.Arch Otolaryngol Head Neck S u rg, 1997,123:984-988.
  • 4Sato K, Kawana M,Nonomura N,et al.Course of IL-1beta, IL-6, IL8, and TNF-alpha in the middle ear fluid of the guinea pig otitis media model induced by nonviable Haemophilus influenzae.Ann Otol Rhinol Laryngol,1999,108:559-563.
  • 5DeMaria TF,Prior RB,Briggs BR, et al.Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion.J Clin Microbiol, 1984,20:15-17.
  • 6Ball SS, Prazma J, Dais CG, et al. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions.Ann Otol Rhinol Laryngol, 1997,106:633-639.
  • 7Van Deventer SJ,Hart M,Van der Poll T, et al.Endotoxin and tumor necrosis factor- α ,interleukin-8 release in human.J Infection Disease, 1993,19:454-461.
  • 8Hebda PA, Alper CM, Doyle WJ,et al. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol,1998,107:501-507.
  • 9Smirnova MG,Birchall JP,Pearson JP.In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol,2002, 122:146-152.
  • 10Baggett HC,Prazma J,Rose AS,et al.The role of glucocorticoids in endotoxin-mediated otitis media with effusion.Arch Otolaryngol Head Neck Surg, 1997, 123:41-46.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部